USP: Stimuli Article on Mutagenic Impurities published for Comments
Recommendation

6/7 October 2026
Since the beginning of September 2022, the stimuli document "Mutagenic Impurities and Potentially Mutagenic Impurities in the USP-NF" has been published for comments on the website of the Pharmacopeial Forum of the USP. Comments and observations on this draft can be submitted until 30 November 2022.
This draft is divided into the following chapters and subchapters:
- Introduction
- USP Options - Alternative Scenarios under Assessment
- Proposed approaches to introduce mutagenic impurity concepts generally into the compendium
- Proposed approaches to address mutagenic impurities at the level of the monograph
- Proposed approaches to alert users to the possible presence of mutagenic impurities, either within or outside of the compendial requirements (through additional information) - Request to stakeholders
- References
To get to the stimuli document "Mutagenic Impurities and Potentially Mutagenic Impurities in the USP-NF" and to comment on it you need to first register on the Pharmacopeial Forum website.
Related GMP News
23.09.2026FDA Warning Letter: serious GMP Deficiencies at a Chinese API Manufacturer
16.09.2026PFAS restriction: Commission highlights Importance of critical Medical Applications
16.09.2026IPEC: Updated Qualification-Guide published
09.09.2026IPEC: New Stability Guide for Excipients Published
12.08.2026FDA Warning Letter for an Indian API Manufacturer
29.07.2026EPRS publishes a Briefing Paper on PFAS


